GlassScriptPhysician profile
Jonathan N Brueggeman
NPI 1790836401
$1,370.96
in general payments reported to CMS, 2019-2025
9 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $13.49 · 2021: $167 · 2022: $295 · 2023: $262 · 2024: $375 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $877.18 | 2019-2024 | Variax, Prostep Mica, Hoffmann |
| Organogenesis INC. | $176.55 | 2019-2025 | Apligraf |
| Axogen | $169.26 | 2023 | Avance Nerve Graft |
| Orthofix Medical, INC. | $51.19 | 2023 | Truelok |
| Smith+Nephew, INC. | $41.55 | 2019 | |
| Bioventus LLC | $14.49 | 2023 | Stimrouter Implantable Kit |
| Depuy Synthes Sales INC. | $13.76 | 2024 | Motoband, Na, N/A |
| True North Surgical INC | $13.49 | 2024 | |
| Kci USA, INC. | $13.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Brueggeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.